Ziegler et al. (2014) demonstrated that BC cells emphasize multiple strategies to sustain BC cell growth, reflected by aberrant expression of tyrosine kinases (i.e., HER2), cellular adhesion molecules, and structural proteins from the plasma membrane that could be considered as potential targets for BC theranostics [167]. This evidence concerns the gene ERBB2 and breast cancer.